Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.

Dario Di PerriRonan TanguyClaude MaletAnnie RobertMarie-Pierre Sunyach

Published in: Journal of neuro-oncology (2020)

In the present series, HFSRT was associated with limited RN risk. Incidence of RN was higher with dose regimens delivering a higher biologically effective dose, as well as in patients having received immunotherapy within 3 months of HFSRT.

Keyphrases

brain metastases
small cell lung cancer
end stage renal disease
radiation therapy
ejection fraction
newly diagnosed
chronic kidney disease
early stage
radiation induced
prognostic factors
risk factors
squamous cell carcinoma
locally advanced